A recombinant fusion toxin based on enzymatic inactive C3bot1 selectively targets macrophages.
BACKGROUND
The C3bot1 protein (~23 kDa) from Clostridium botulinum ADP-ribosylates and thereby inactivates Rho. C3bot1 is selectively taken up into the cytosol of monocytes/macrophages but not of other cell types such as epithelial cells or fibroblasts. Most likely, the internalization occurs by a specific endocytotic pathway via acidified endosomes.


RESULTS
Here, we tested whether enzymatic inactive C3bot1E174Q serves as a macrophage-selective transport system for delivery of enzymatic active proteins into the cytosol of such cells. Having confirmed that C3bot1E174Q does not induce macrophage activation, we used the actin ADP-ribosylating C2I (∼50 kDa) from Clostridium botulinum as a reporter enzyme for C3bot1E174Q-mediated delivery into macrophages. The recombinant C3bot1E174Q-C2I fusion toxin was cloned and expressed as GST-protein in Escherichia coli. Purified C3bot1E174Q-C2I was recognized by antibodies against C2I and C3bot and showed C2I-specific enzyme activity in vitro. When applied to cultured cells C3bot1E174Q-C2I ADP-ribosylated actin in the cytosol of macrophages including J774A.1 and RAW264.7 cell lines as well as primary cultured human macrophages but not of epithelial cells. Together with confocal fluorescence microscopy experiments, the biochemical data indicate the selective uptake of a recombinant C3-fusion toxin into the cytosol of macrophages.


CONCLUSIONS
In summary, we demonstrated that C3bot1E174Q can be used as a delivery system for fast, selective and specific transport of enzymes into the cytosol of living macrophages. Therefore, C3-based fusion toxins can represent valuable molecular tools in experimental macrophage pharmacology and cell biology as well as attractive candidates to develop new therapeutic approaches against macrophage-associated diseases.
Institute of Pharmacology and Toxicology, University of Ulm Medical Center, Ulm, Germany.
Lydia
L
Dmochewitz
Christina
C
Förtsch
Christian
C
Zwerger
Martin
M
Vaeth
Edward
E
Felder
Markus
M
Huber-Lang
Holger
H
Barth
D036002:ADP Ribose Transferases / Q000235:genetics* / Q000378:metabolism; D001427:Bacterial Toxins / Q000235:genetics / Q000378:metabolism; D001692:Biological Transport / Q000235:genetics; D002478:Cells, Cultured; D003014:Clostridium botulinum / Q000201:enzymology / Q000235:genetics* / Q000378:metabolism; D003600:Cytosol / Q000201:enzymology / Q000378:metabolism; D004926:Escherichia coli; D006801:Humans; D008262:Macrophage Activation; D008264:Macrophages / Q000166:cytology / Q000201:enzymology / Q000378:metabolism; D009000:Monocytes / Q000166:cytology / Q000201:enzymology / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000235:genetics* / Q000378:metabolism
D001427:Bacterial Toxins; D011993:Recombinant Fusion Proteins; D036002:ADP Ribose Transferases